Παραπομπή APA

Cifuentes, S., Alferez, I., Paz, S. C., Guindo, P. N., Cuadrado, E. M., & García, F. (2018). 4CPS-135 Effectiveness and cost of eculizumab on patients with atypical (shua), urenic and haemolitic syndrome, with enlargement of the frequency of administration. Eur J Hosp Pharm.

Παραπομπή Chicago Style

Cifuentes, S., I. Alferez, S Cañizares Paz, P Nieto Guindo, E Molina Cuadrado, και FSierra García. "4CPS-135 Effectiveness and Cost of Eculizumab On Patients With Atypical (shua), Urenic and Haemolitic Syndrome, With Enlargement of the Frequency of Administration." Eur J Hosp Pharm 2018.

Παραπομπή MLA

Cifuentes, S., et al. "4CPS-135 Effectiveness and Cost of Eculizumab On Patients With Atypical (shua), Urenic and Haemolitic Syndrome, With Enlargement of the Frequency of Administration." Eur J Hosp Pharm 2018.

Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.